Mouse Microsurgery Core

小鼠显微外科核心

基本信息

  • 批准号:
    9750611
  • 负责人:
  • 金额:
    $ 16.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

CORE B - SUMMARY/ABSTRACT The Mouse Liver Microsurgery Core (Core B) will be responsible for conducting liver transplant surgery procedures and post-transplant care in mice in this PPG initiative. The orthotopic liver transplantation (OLT) procedures in mice are technically highly demanding, and the maintenance of surgical technical quality and stability will be the key for the experimental success. Core B therefore will provide all the surgical assistance to the investigators in conducting liver warm ischemia as well as ex vivo liver cold ischemia combined with OLT, as outlined in Project I and Project II. The core will also coordinate experiments among the projects to maximize the use of samples from transplants and minimize the number of animals for transplant surgery. In addition, extra samples from transplants will be stored and maintained as the archive. If the Project requires additional surgical procedures, Core B will also provide support for other surgical needs in the proposals. The laboratory has developed the mouse model of extended hepatic cold storage and OLT a decade ago to study various aspects of innate and adaptive immune responses in organ transplantation. Significant amounts of experience, accumulated data, and available models will enable us to confidently conduct the complicated experiments in this Project. The specific aims of Core B are as follows: Aim 1. To provide OLT and local liver IRI surgery and post-transplant care in mice with quality and consistency. The core will be responsible for conducting all the microsurgical OLT/non-transplant procedures and post- transplant care in mice in Project 1 and 2. These procedures are technically demanding, and the Core will assure consistent and reliable surgical outcomes in conducting experiments, as proposed in this PPG. Aim 2. To coordinate experiments among projects and maximize the use of samples from liver transplants and recipients. The Core will coordinate experiments between Project I and Project II to maximize the use of samples from transplanted animals and thus to minimize the numbers and costs of animals for surgeries. Aim 3. To store extra samples and maintain the archive. The Core will store and record surplus tissue samples (liver grafts, host tissues, serum) and maintain them as an archive for potential future use. Aim 4. To provide support for other surgical needs. Core B will provide support for additional surgical procedures (e.g., portal vein injections; i.v. infusions), if needed.
核心B -总结/摘要 小鼠肝脏显微外科核心(核心B)将负责进行肝脏移植手术 程序和移植后护理的小鼠在这个PPG倡议。原位肝移植(奥尔特) 小鼠手术在技术上要求很高,维持手术技术质量和 稳定性将是实验成功的关键。因此,核心B将提供所有手术辅助, 研究者在进行肝脏热缺血以及离体肝脏冷缺血联合奥尔特中, 在项目I和项目II中概述。核心还将协调项目之间的实验,以最大限度地提高 使用来自移植的样本,并最大限度地减少移植手术的动物数量。此外,额外 移植的样本将作为档案储存和维护。如果项目需要额外的手术 核心B还将为提案中的其他手术需求提供支持。实验室已 十年前,我开发了延长肝脏冷藏和奥尔特的小鼠模型,以研究各个方面 先天性和适应性免疫反应在器官移植中的作用。丰富的经验, 积累的数据和可用的模型将使我们能够自信地进行复杂的实验, 这个项目核心B的具体目标如下: 目标1。为小鼠提供高质量和一致性的奥尔特和局部肝脏IRI手术和移植后护理。 核心将负责进行所有的显微外科奥尔特/非移植程序和术后 在项目1和项目2中的小鼠移植护理。这些程序在技术上要求很高,核心将 如本PPG所述,在进行实验时确保一致和可靠的手术结果。 目标二。协调各项目之间的实验,最大限度地利用肝脏移植样本, 受惠人士核心将协调项目I和项目II之间的实验,以最大限度地利用样本 从而最大限度地减少手术动物的数量和成本。 目标3。储存额外样本并维护存档。核心将储存并记录剩余组织样本 (肝移植物、宿主组织、血清),并将其作为档案保存,以备将来使用。 目标4。为其他手术需求提供支持。核心B将为额外的外科手术提供支持 (e.g.,门静脉注射;静脉内输注)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Haofeng Ji其他文献

Haofeng Ji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Haofeng Ji', 18)}}的其他基金

YAP-IRGM1 REGULATES HEPATIC INFLAMMATION IN ORTHOTOPIC LIVER TRANSPLANTATION
YAP-IRGM1 调节原位肝移植中的肝脏炎症
  • 批准号:
    10350169
  • 财政年份:
    2022
  • 资助金额:
    $ 16.81万
  • 项目类别:
YAP-IRGM1 REGULATES HEPATIC INFLAMMATION IN ORTHOTOPIC LIVER TRANSPLANTATION
YAP-IRGM1 调节原位肝移植中的肝脏炎症
  • 批准号:
    10605200
  • 财政年份:
    2022
  • 资助金额:
    $ 16.81万
  • 项目类别:
Mouse Microsurgery Core
小鼠显微外科核心
  • 批准号:
    9975695
  • 财政年份:
    2017
  • 资助金额:
    $ 16.81万
  • 项目类别:
PACAP Mediated Neural Regulation of Hepatic Inflammation in Orthotopic Liver Transplantation
PACAP 介导原位肝移植中肝脏炎症的神经调节
  • 批准号:
    9018794
  • 财政年份:
    2016
  • 资助金额:
    $ 16.81万
  • 项目类别:
PACAP Mediated Neural Regulation of Hepatic Inflammation in Orthotopic Liver Transplantation
PACAP 介导原位肝移植中肝脏炎症的神经调节
  • 批准号:
    9248242
  • 财政年份:
    2016
  • 资助金额:
    $ 16.81万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 16.81万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 16.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了